Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Aoqui, Cristiane ^a   Chmielewski, Stefan ^a,b   Scherer, Elias ^a   Eißler, Ruth ^a   Sollinger, Daniel ^a   Heid, Irina ^a   Braren, Rickmer ^a   Schmaderer, Christoph ^a   Megens, Remco T A ^c,d   Weber, Christian ^c,d,e   Heemann, Uwe ^a   Tschöp, Matthias ^f   Baumann, Marcus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

High fat diet; Hypertension; Metabolic syndrome; Microvascular dysfunction; Vasoconstriction

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; EPIDIDYMIS FAT; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; MALE; MESENTERY BLOOD FLOW; METABOLIC SYNDROME X; MICROANGIOPATHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; RISK ASSESSMENT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; DIET, HIGH-FAT; MALE; MESENTERIC ARTERIES; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICROVESSELS; ORGAN CULTURE TECHNIQUES; VASOCONSTRICTION;

EID: 84893191273     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-31     Document Type: Article

References (56)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952. 10.1016/S0140-6736(04)17018-9, 15364185.
2. Alberti KG, Zimmet P, Shaw J, Group IDFETFC The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8, 16182882, Group IDFETFC.
3. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, American Heart A, National Heart L, Blood I. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958.
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214. 10.2337/diabetes.52.5.1210, 12716754.
5. Deboer MD. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 2013, 29:379-386. 10.1016/j.nut.2012.07.003, 3578702, 23022122.
6. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121:230-236. 10.1161/CIRCULATIONAHA.109.887521, 20038741.
7. Rossi M, Matteucci E, Pesce M, Consani C, Franzoni F, Santoro G, Giampietro O. Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: a preliminary study. Hemorheol Microcirc 2012, 54:381-391.
8. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment?. Circulation 2001, 104:735-740. 10.1161/hc3101.091158, 11489784.
9. Mulvany MJ. Structure and function of small arteries in hypertension. J Hypertens Suppl 1990, 8:S225-232.
10. Panazzolo DG, Sicuro FL, Clapauch R, Maranhao PA, Bouskela E, Kraemer-Aguiar LG. Obesity, metabolic syndrome, impaired fasting glucose, and microvascular dysfunction: a principal component analysis approach. BMC Cardiovasc Disord 2012, 12:102. 10.1186/1471-2261-12-102, 3534385, 23148545.
11. Hrnciar J, Avdicova M, Gabor D, Hrnciarova M, Chamulova M, Jakubikova K, Kaliska G, Kikova V, Kovar F, Kreze A, et al. Prevalence of metabolic syndrome, insulin resistance, and microvascular angina pectoris in 500 consecutive patients referred to coronarography. Endocr Regul 2013, 47:33-38. 10.4149/endo_2013_01_33, 23363255.
12. Pirat B, Bozbas H, Simsek V, Yildirir A, Sade LE, Gursoy Y, Altin C, Atar I, Muderrisoglu H. Impaired coronary flow reserve in patients with metabolic syndrome. Atherosclerosis 2008, 201:112-116. 10.1016/j.atherosclerosis.2008.02.016, 18374338.
13. Yudkin JS, Eringa E, Stehouwer CD. " Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005, 365:1817-1820. 10.1016/S0140-6736(05)66585-3, 15910955.
14. Muris DM, Houben AJ, Schram MT, Stehouwer CD. Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance. Rev Endocr Metab Disord 2013, 14:29-38. 10.1007/s11154-012-9231-7, 23299657.
15. Stapleton PA, Goodwill AG, James ME, Brock RW, Frisbee JC. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond) 2010, 7:54. 10.1186/1476-9255-7-54, 2996379, 21087503.
16. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009, 119:1661-1670. 10.1161/CIRCULATIONAHA.108.821181, 19289637.
17. Stapleton PA, James ME, Goodwill AG, Frisbee JC. Obesity and vascular dysfunction. Pathophysiology 2008, 15:79-89. 10.1016/j.pathophys.2008.04.007, 2593649, 18571908.
18. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004, 44:271-276. 10.1161/01.HYP.0000140058.28994.ec, 15302842.
19. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002, 16:1057-1063. 10.1096/fj.02-0024com, 12087067.
20. Schmid PM, Resch M, Steege A, Fredersdorf-Hahn S, Stoelcker B, Birner C, Schach C, Buechler C, Riegger GA, Luchner A, Endemann DH. Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats. Am J Hypertens 2011, 24:270-277. 10.1038/ajh.2010.239, 21151013.
21. Cao Y, Tao L, Yuan Y, Jiao X, Lau WB, Wang Y, Christopher T, Lopez B, Chan L, Goldstein B, Ma XL. Endothelial dysfunction in adiponectin deficiency and its mechanisms involved. J Mol Cell Cardiol 2009, 46:413-419. 10.1016/j.yjmcc.2008.10.014, 2671019, 19027750.
22. Schmid PM, Resch M, Schach C, Birner C, Riegger GA, Luchner A, Endemann DH. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats. Cardiovasc Diabetol 2013, 12:46. 10.1186/1475-2840-12-46, 3606629, 23497197.
23. Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, Alloosh M, Sturek M, Tune JD. Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013, 128:9-18. 10.1161/CIRCULATIONAHA.112.001238, 23685742.
24. Oliveira Junior SA, Padovani CR, Rodrigues SA, Silva NR, Martinez PF, Campos DH, Okoshi MP, Okoshi K, Dal-Pai M, Cicogna AC. Extensive impact of saturated fatty acids on metabolic and cardiovascular profile in rats with diet-induced obesity: a canonical analysis. Cardiovasc Diabetol 2013, 12:65. 10.1186/1475-2840-12-65, 3679825, 23587409.
25. Sarkozy M, Zvara A, Gyemant N, Fekete V, Kocsis GF, Pipis J, Szucs G, Csonka C, Puskas LG, Ferdinandy P, Csont T. Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats. Cardiovasc Diabetol 2013, 12:16. 10.1186/1475-2840-12-16, 3599923, 23320804.
26. Gallou-Kabani C, Vige A, Gross MS, Rabes JP, Boileau C, Larue-Achagiotis C, Tome D, Jais JP, Junien C. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 2007, 15:1996-2005. 10.1038/oby.2007.238, 17712117.
27. Christensen KL, Mulvany MJ. Location of resistance arteries. J Vasc Res 2001, 38:1-12.
28. Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 1993, 30:73-79. 10.1159/000158978, 8504198.
29. Fenger-Gron J, Mulvany MJ, Christensen KL. Mesenteric blood pressure profile of conscious, freely moving rats. J Physiol 1995, 488(Pt 3):753-760. 1156740, 8576864.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
31. Mather K. Surrogate measures of insulin resistance: of rats, mice, and men. Am J Physiol Endocrinol Metab 2009, 296:E398-399.
32. Megens RT, Reitsma S, Schiffers PH, Hilgers RH, De Mey JG, Slaaf DW, oude Egbrink MG, van Zandvoort MA. Two-photon microscopy of vital murine elastic and muscular arteries. Combined structural and functional imaging with subcellular resolution. J Vasc Res 2007, 44:87-98. 10.1159/000098259, 17192719.
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
34. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977, 41:19-26. 10.1161/01.RES.41.1.19, 862138.
35. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008, 114:361-374. 10.1042/CS20070347, 18230060.
36. International Diabetes Federation. http://www.idf.org/publications.
37. Jebelovszki E, Kiraly C, Erdei N, Feher A, Pasztor ET, Rutkai I, Forster T, Edes I, Koller A, Bagi Z. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am J Physiol Heart Circ Physiol 2008, 294:H2558-2564. 10.1152/ajpheart.01198.2007, 18408126.
38. Singer G, Granger DN. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation 2007, 14:375-387. 10.1080/10739680701283158, 17613809.
39. Ouwens DM, Sell H, Greulich S, Eckel J. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 2010, 14:2223-2234. 10.1111/j.1582-4934.2010.01141.x, 20716126.
40. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 2004, 109:42-46. 10.1161/01.CIR.0000116602.10533.2E, 14676144.
41. Doyle AE, Fraser JR, Marshall RJ. Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sci 1959, 18:441-454.
42. Doyle AE, Fraser JR. Vascular reactivity in hypertension. Circ Res 1961, 9:755-761. 10.1161/01.RES.9.3.755, 13724177.
43. Ritchie RH, Leo CH, Qin C, Stephenson EJ, Bowden MA, Buxton KD, Lessard SJ, Rivas DA, Koch LG, Britton SL, et al. Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function. Am J Physiol Heart Circ Physiol 2013, 304:H729-739. 10.1152/ajpheart.00638.2012, 23262135.
44. Withers SB, Agabiti-Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA, Heagerty AM. Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol 2011, 31:908-913. 10.1161/ATVBAHA.110.221705, 21273560.
45. Aghamohammadzadeh R, Greenstein AS, Yadav R, Jeziorska M, Hama S, Soltani F, Pemberton PW, Ammori B, Malik RA, Soran H, Heagerty AM. Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity. J Am Coll Cardiol 2013, 62:128-135. 10.1016/j.jacc.2013.04.027, 3791397, 23665100.
46. Sharma AM. Is there a rationale for angiotensin blockade in the management of obesity hypertension?. Hypertension 2004, 44:12-19. 10.1161/01.HYP.0000132568.71409.a2, 15173127.
47. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001, 15:2727-2729.
48. Yiannikouris F, Gupte M, Putnam K, Thatcher S, Charnigo R, Rateri DL, Daugherty A, Cassis LA. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012, 60:1524-1530. 10.1161/HYPERTENSIONAHA.112.192690, 3517298, 23108647.
49. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362. 10.2337/dc05-1801, 16732021.
50. Hilgers RH, Webb RC. Molecular aspects of arterial smooth muscle contraction: focus on Rho. Exp Biol Med (Maywood) 2005, 230:829-835.
51. Wirth A. Rho kinase and hypertension. Biochim Biophys Acta 1802, 2010:1276-1284.
52. Liu PY, Chen JH, Lin LJ, Liao JK. Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. J Am Coll Cardiol 2007, 49:1619-1624. 10.1016/j.jacc.2006.12.043, 2615567, 17433952.
53. Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, et al. Calcium channel blocker and Rho-associated kinase activity in patients with hypertension. J Hypertens 2011, 29:373-379. 10.1097/HJH.0b013e328340902d, 3807090, 21063203.
54. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 2001, 89:488-495. 10.1161/hh1801.096337, 11557735.
55. Moriki N, Ito M, Seko T, Kureishi Y, Okamoto R, Nakakuki T, Kongo M, Isaka N, Kaibuchi K, Nakano T. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004, 27:263-270. 10.1291/hypres.27.263, 15127884.
56. Hara Y, Wakino S, Tanabe Y, Saito M, Tokuyama H, Washida N, Tatematsu S, Yoshioka K, Homma K, Hasegawa K, et al. Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch. Sci Signal 2011, 4:ra3.